Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature

Author:

Gjelberg Hilde K.1,Helgeland Lars12,Liseth Knut3,Micci Francesca4,Sandnes Miriam5,Russnes Hege G.678,Reikvam Håkon59ORCID

Affiliation:

1. Department of Pathology, Haukeland University Hospital, N-5021 Bergen, Norway

2. Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway

3. Department of Immunology and Transfusion Medicine, Haukeland University Hospital, N-5021 Bergen, Norway

4. Section for Cancer Cytogenetics, Institute of Cancer Genetics and Informatics, Oslo University Hospital, N-0424 Oslo, Norway

5. Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway

6. Department of Pathology, Oslo University Hospital, N-0424 Oslo, Norway

7. Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, N-0424 Oslo, Norway

8. Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, N-0424 Oslo, Norway

9. Department of Medical Science, University of Bergen, N-5021 Bergen, Norway

Abstract

T-prolymphocytic leukemia (T-PLL) is a rare malignancy of mature T-cells with distinct clinical, cytomorphological, and molecular genetic features. The disease typically presents at an advanced stage, with marked leukocytosis, B symptoms, hepatosplenomegaly, and bone marrow failure. It usually follows an aggressive course from presentation, and the prognosis is often considered dismal; the median overall survival is less than one year with conventional chemotherapy. This case report describes a patient with T-PLL who, after an unusually protracted inactive phase, ultimately progressed to a highly invasive, organ-involving disease. After initial treatments failed, a novel treatment approach resulted in a significant response.

Publisher

MDPI AG

Reference24 articles.

1. Lim, M. (2023, September 01). T-prolymphocytic leukaemia, WHO Classification of Tumours Online, Haematolymphoid Tumours, Available online: https://tumourclassification.iarc.who.int/chaptercontent/63/209.

2. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia;Matutes;Blood,1991

3. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL);Jain;Ann. Oncol.,2017

4. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia;Herling;Blood,2008

5. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d’Hématologie Cellulaire;Garand;Br. J. Haematol.,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3